Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial.
Journal: Dermatology and therapy
Published: January 27, 2026
Selection of Nemolizumab Clinical Dosage for Atopic Dermatitis.
Journal: Journal of drugs in dermatology : JDD
Published: October 06, 2023
Aromatherapy, botanicals, and essential oils in acne.
Journal: Clinics in dermatology
Published: June 18, 2018
Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified-release capsules in a randomized trial.
Journal: Journal of the American Academy of Dermatology
Published: May 30, 2015
The use of a reliable, ubiquitous, inexpensive, and user-friendly tablet-based system to track target lesion improvements in subjects with plaque psoriasis treated with clobetasol propionate 0.05% spray.
Journal: Journal of drugs in dermatology : JDD
Published: March 05, 2015
Efficacy, safety, and subject satisfaction of a specified skin care regimen to cleanse, medicate, moisturize, and protect the skin of patients under treatment for acne vulgaris.
Journal: The Journal of clinical and aesthetic dermatology
Published: January 23, 2015
Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray.
Journal: Journal of drugs in dermatology : JDD
Published: December 05, 2013
Showing 1-7 of 7
Last Updated: 09/26/2026